ViaGenetics® Intellectual Property

ViaGenetics has filed 20 first-to-file patent applications designed to protect broad areas surrounding our discoveries and development of diagnostics and therapies.

Richard Postrel, Tony Barkume and George Jones lead our intellectual property team.


Their combined expertise and systematic approach to patent development has historically resulted in an extremely high success rate.

Application #62/400,621


Filed – 09-27-2016

Method for treatment of disease with plaque etiology

Application #15/222,955


Filed – 07-29-2016

Mitochondrial Balancing Method for Medical Treatment

Application #62/460,997


Filed – 02-20-2017

System and Method for Targeting and Destroying Cancerous and Pre-Cancerous Cells Through Heat Signatures and Other Biomarkers

Application #62/510,442


Filed – 05-24-2017

Method for Producing Synthetic Vaccines for Rapid Response and High Volume Capacity

Application #62/540,833


Filed – 08-03-2017

Managing Intercellular Communications

Application #62/551,748


Filed – 08-29-17

Method and System for the Diagnosis, Prevention or Treatment of Alzheimer's and Related Disease by Measuring, Inhibiting or Arresting Amyloid Plaque Development

Application #15/719,322


Filed – 09-28-17

A Method for Rapid High Volume Production of Synthetic Vaccines

Application #62/464,165


Filed – 02-27-2017

Treating Alzheimer’s Disease by Rebalancing Mitochondrial Metabolism

Application #62/407,819


Filed – 11-03-2016

Method for treatment of disease with plaque etiology

Application #62/482,192


Filed – 04-06-2017

Facile Method of Diagnosing, Reversing and Monitoring Cells Expressing Misdirected Metabolisms

Application #62/529,551


Filed – 07-07-2017

Methods and Systems for Cell-to-Cell Restoration Therapy using Subcellular Transactions

Application #62/545,740


Filed – 08-15-2017

Synthetic Smart Membrane for Surgical and Post-Surgical Wound Treatment

Application #62/553,801


Filed – 09-02-17

Method and Treatment for Arresting Arthritis, Diabetes, Multiple Sclerosis and other Inflammatory/Autoimmune Conditions Arising from CLEC16A Dysfunctioning

Application #62/595043


Filed – 12-05-17

Directing Cancer Cells to Self- Destruct Through Vectoring Engineered Viruses

Application #62/504,850


Filed – 05-11-2017

Primary Methods and Processes for Life Extension

Application #62/450,328


Filed – 01-25-2017

Comprehensive Management of Diseased Cell Energetics for Cancer Cell Detection, Triggering

Application #62/510,268


Filed – 05-23-2017

System and Method for Native Protein Production as Required

Application #62/537,031


Filed – 07-26-2017

Methods and Systems for Cell-to-Cell Restoration (Anti-Aging and Disease Prevention) Therapy Using Subcellular Transactions

Application #62/551,273


Filed – 08-29-2017

Process and Method for Hyper-

Nanotube Development to Improve and Accelerate Healing and Wound Management

Application #15/808,563


Filed – 11-09-17

System and Method for Managing All Cancers by Disabling the Cancer Cells Ability to Reproduce

© 2017 ViaGenetics® All Rights Reserved.

(305) 865-7000

5244 North Bay Road, Miami Beach, FL 33140

© 2017 ViaGenetics® All Rights Reserved.